Nuvation Stock 190% Despite: Insider Sale Insights for Investors
Nuvation Bio has surged, even as an insider sold a meaningful stake. This piece breaks down what the move means, how ...
Glide paths in target date funds describe how asset allocations shift automatically as retirement nears, balancing growth and risk over time. This intro explains the idea and why it matters for planning.
25,488 articlesNuvation Bio has surged, even as an insider sold a meaningful stake. This piece breaks down what the move means, how ...
Solopreneurs risk treating their business as retirement, but a year-end Solo 401K deadline offers a tax-advantaged pa...
As July 18, 2026 approaches, the GENIUS Act deadline accelerates rulemaking for stablecoin issuers. Regulators from T...
A niche bond ETF focused on mid-tier CLO tranches is drawing buyers as rate expectations stay elevated. The fund aims...
SVB Capital, the bank's roughly $10 billion venture arm, is being shopped as regulators unwind SVB assets. Buyers are...
Bitcoin hovers around 82,000 as traders assess whether the bear market bottom when will be confirmed. A sustained ETF...
The AI boom isn’t just about memory chips anymore. A broader wave of demand is lifting compute, software, and data in...
Eating out is a daily ritual for many families. This guide shows you how to choose credit card dining rewards that ac...
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
UPS has faced a rough stretch, but signs of a turnaround are catching investor attention. This guide explains why Jul...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...